![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 14, 2013 3:52:54 PM
That being said, with sales at $8,000,000 per year it is not unreasonable to assume that in 18 months revenues could rise to $25 million per year based on a successful marketing and sales program.
The current price is approximately 41 cents. If the goal is $4 in 18 months, on average that would be a twenty cent gain per month, which to me is very reasonable and achievable if, indeed, revenue increases steadily.
It seems to me that calls on this board for daily share price increases of more than twenty cents is getting way ahead of a rational share price for this company. Steady seems to be the way to go as the company competes successfully in the area of rapidly absorbed drugs.
I would like to begin buying shares again in this company but will wait until the share price appears rational and excessive claims of daily gains abate.
All in my opinion. Best wishes and good luck.
Trueheart
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM